The annual spring congregation of egg-laden horseshoe crabs on the east coast provide a vital food source for annual migrations of millions of shore birds.
The $18 billion gold rush for liability free COVID vaccines now threatens that ancient Atlantic coast ritual. COVID vaccine makers plot to harvest tens of thousands of these primitive and beloved sea creatures. The horseshoe crab’s blue blood is the only known natural source of limulus amebocyte lysate, a substance that detects and eliminates a potentially deadly vaccine contaminant called endotoxin.
In 1990, biologists estimated 1.24 million crabs spawned in Delaware Bay, a main egg-laying nursery grounds and prime collection point for the companies. By 2019, that number had dropped to 335,211. Conservation groups feel that the planned harvest by vaccine manufacturers may lead to the species’ extinction.
Starting in July, Swiss-based Lonza will begin manufacturing a COVID-19 vaccine for human clinical trials. The company will use lysate in the vaccine it plans to sell it in the U.S.
The horseshoe crab is already on the brink of extinction. Conservationists fear that the demand for horseshoe crab blood for COVID-19 vaccines may exterminate the crabs and destroy the shore birds and the marine ecosystem that depend on them.
Conservationists observe that the harvesting of wild animals like sharks and horseshoe crabs for exploding vaccine manufacturing is unsustainable.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
